Family · Pharmaceutical analytical standards
Ofloxacin
A second-generation fluoroquinolone antibiotic, patented in 1980 and first approved in Japan in 1985, that blocks bacterial DNA gyrase and is used against many infections. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, nitrosamines and other impurities.
Did you know?It is a mixture of two mirror-image forms: the (S) form, separated later, became a drug in its own right, levofloxacin, on the market since 1993.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
